Director Dealing

28 December 2011

Phorm, Inc. ("Phorm" or the "Company")

Director Dealing

Phorm (AIM: PHRM and PHRX) announces that on December 28th Kent Ertugrul, CEO and Chairman of the Company, transferred for nil consideration 2,594,412 shares in the Company to Value Trust Holdings Pte Ltd limited for tax planning purposes.

For Enquiries

Phorm, Inc.

Andy Croxson (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Advisor)

Simon Bridges, Andrew Chubb